http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PH-12017501191-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb73e53c487a4191781d081bba0bf81d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40765ca9a78b54a8a76f781d159ad145
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
filingDate 2017-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59958a6c9563c065d789d54a9376b58b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80f5f4a44eec31efb4d999e395b94e83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_358509c5f6e2637b0d580e95eb2edc0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8628f8a5051d3f55fa797771244ef04e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96c296e81d549b8bce259222bb472137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_055f554ca603ff2565ce9fdbd94bbb5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cf37c4a054a6cbd8d11a7b8eaaa6600
publicationDate 2018-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PH-12017501191-A1
titleOfInvention Quinazoline derivatives used to treat hiv
abstract Described herein are compounds of Formula (I) and tautomers and pharmaceutical salts thereof, compositions and formulations containing such compounds, and methods of using and making such compounds.
priorityDate 2014-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457490761

Total number of triples: 32.